On Monday, the prominent US agency said that AstraZeneca may have used “old” data during its clinical trials in the United States on Corona Vaccine.
“We are urging the company to work with the Data and Safety Monitoring Board to assess.” Data effectivenessAnd to ensure that the most accurate, up-to-date and effective data will be published as quickly as possible, “according to” AFP. “
Several countries previously suspended the use of the AstraZeneca vaccine earlier this month due to fears that it could cause clots, which in some cases may be fatal..
But European Medicines Agency It confirmed that it was “safe and effective,” and its use was resumed in several countries.